Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
T cells Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023 24 0
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022 63 3
BNT162b2 Approved by FDA Experimental Vaccine Jul/11/2022 66 0
N(4)-Hydroxycytidine Potential treatment - pre-clinical evidence Experimental Antiviral Jul/04/2022 6 0
Molnupiravir Emergency use authorization Experimental Antiviral Jun/23/2022 17 1
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
NK cells Potential treatment - theoretical effect Used to treat other disease Antiviral Dec/23/2021 6 0
S2H97 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 2 0
S2X259 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 2 0
Excel (.xslx) CSV (.csv)